Overview
Use this article to understand how appetite and body weight may change after pausing or stopping GLP-1 or GIP weight-loss medication, why contacting your care team is important, and when a new medical consultation is required.
Physiological changes after stopping treatment
Discontinuing GLP-1 or GIP receptor agonist treatment leads to the gradual clearance of the active ingredient from your body:
Return of natural appetite: As the medication leaves your system, its appetite-suppressing and satiety-enhancing effects diminish. Pre-treatment feelings of hunger and food cravings will naturally return.
Potential for weight regain: Without the physiological support of the medication regulating gastric emptying and appetite signals, body weight may gradually increase if dietary calorie intake increases.
Clinical clarification on stopping: Pausing or stopping weight-loss medication does not cause addictive withdrawal symptoms. The return of increased appetite and food cravings is simply the physiological result of losing the active hormone mimicry provided by the treatment.
Pausing, restarting, and consulting your care team
If you are considering pausing or discontinuing your weight-loss treatment, it is important to manage the transition safely under medical guidance.
Consult your care team first: Contact MedExpress or your primary care physician before stopping treatment to discuss your progress, address any side effects, or plan a safe transition.
Restarting treatment after a pause: If treatment is paused for several weeks or more, your body's tolerance to the medication decreases. You must complete a new medical assessment before restarting treatment, as returning to a higher dose directly could cause severe gastrointestinal side effects. Re-titration from the lowest starting dose may be required.
Additional Assistance
If you still need help after reviewing the information above, additional assistance is available.